Prognostic impact of MRP3 expression using quartiles and thirds as cutoffs for high and low expression in patients who were treated only in the studies ALL-BFM 90/95 or 2000 (n = 45)
. | Low expression of MRP3 . | . | High expression of MRP3 . | . | . | ||
|---|---|---|---|---|---|---|---|
| Percentile used as cutoff . | Overall survival after 5 years, % . | Standard error, % . | Overall survival after 5 years, % . | Standard error, % . | Log-rank test, P . | ||
| 25 | 100 | * | 87 | 6 | .21 | ||
| 33 | 100 | * | 85 | 7 | .14 | ||
| 50 | 100 | * | 80 | 9 | .04 | ||
| 66 | 96 | 4 | 79 | 11 | .07 | ||
| 75 | 93 | 5 | 82 | 12 | .28 | ||
. | Low expression of MRP3 . | . | High expression of MRP3 . | . | . | ||
|---|---|---|---|---|---|---|---|
| Percentile used as cutoff . | Overall survival after 5 years, % . | Standard error, % . | Overall survival after 5 years, % . | Standard error, % . | Log-rank test, P . | ||
| 25 | 100 | * | 87 | 6 | .21 | ||
| 33 | 100 | * | 85 | 7 | .14 | ||
| 50 | 100 | * | 80 | 9 | .04 | ||
| 66 | 96 | 4 | 79 | 11 | .07 | ||
| 75 | 93 | 5 | 82 | 12 | .28 | ||
Standard errors cannot be computed if survival is 100%.